8th NovAliX Conference

Biophysics in Drug Discovery 2020 | US Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Boston, MA, United States    June 15-17, 2020

Committees


Conference Chairman

Chairman

Dr Jean-Paul RENAUD

Urania Therapeutics, Illkirch, France

Scientific Committee

Members

Prof. Michelle ARKIN

University of California, San Francisco, United States

Dr Jim BRYSON

Bristol-Myers-Squibb, Princeton, United States

Dr Dirksen BUSSIERE

Novartis, Emeryville, United States

Dr Claudio CIFERRI

Genentech, South San Francisco, United States

Dr MariJean EGGEN

Eli Lilly, Indianapolis, United States

Dr Dan ERLANSON

Frontier Medicines, South San Francisco, United States

Dr Jean-Paul RENAUD

Urania Therapeutics, Illkirch, France

Dr Chaohong SUN

Abbvie, North Chicago, United States

Dr Daniel WYSS

Merck, Kenilworth, United States

Dr Denis ZEYER

NovAliX, Illkirch, France